ChiefNode

Perhaps we can solve one drug problem

The Wall Street Journal article on how to incentivize drug companies to look for solutions to new public health problems (avian flu, terrorist-leaked items) focuses still on problems which impact the entire US population. Foreign populations, and niche conditions are ignored. UC Berkeley's socially responsible licensing program provides incentives for companies (or other organizations) to create and deliver drugs to less - developed nations, and the NIH has started at least one program to try to get niche disease/condition drugs developed. But we need a broader solution.

posted by Dana Bostrom @ 15:29